MAI Capital Management’s LifeMD LFMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$420K Buy
101,627
+1,555
+2% +$6.86K ﹤0.01% 1397
2026
Q1
$361K Buy
100,072
+72
+0.1% +$249 ﹤0.01% 1169
2025
Q4
$341K Hold
100,000
﹤0.01% 1104
2025
Q3
$679K Hold
100,000
﹤0.01% 825
2025
Q2
$1.36M Hold
100,000
0.01% 577
2025
Q1
$544K Hold
100,000
﹤0.01% 794
2024
Q4
$495K Hold
100,000
﹤0.01% 848
2024
Q3
$524K Hold
100,000
0.01% 727
2024
Q2
$686K Hold
100,000
0.01% 704
2024
Q1
$1.03M Hold
100,000
0.01% 571
2023
Q4
$829K Hold
100,000
0.01% 524
2023
Q3
$625K Hold
100,000
0.01% 562
2023
Q2
$435K Hold
100,000
0.01% 696
2023
Q1
$170K Hold
100,000
﹤0.01% 961
2022
Q4
$194K Hold
100,000
﹤0.01% 915
2022
Q3
$197K Buy
+100,000
New +$238K ﹤0.01% 840

Other funds holding LFMD

MAI Capital Management's LFMD Position: Q2 2026 in Review

MAI Capital Management increased its LifeMD (LFMD) stake by 1.6% in Q2 2026, buying an estimated $6.86K and bringing the position to 101,627 shares worth $420K. The position accounts for ﹤0.01% of the portfolio, ranked #1397.

MAI Capital Management first reported a position in LFMD in Q3 2022 and has held it in 16 quarters since. The position peaked at $1.36M in Q2 2025. 116 funds tracked by Wall St. Rank hold LFMD as of Q2 2026.

  • MAI Capital Management held 101,627 shares of LifeMD worth $420K as of Q2 2026.
  • MAI Capital Management bought 1,555 LifeMD shares in Q2 2026, an estimated $6.86K.
  • LifeMD made up ﹤0.01% of MAI Capital Management's portfolio in Q2 2026, its #1397 holding.
  • MAI Capital Management first reported a position in LifeMD in Q3 2022 and has held it in 16 quarters since.
  • MAI Capital Management's LifeMD position peaked at $1.36M in Q2 2025.
  • 116 funds tracked by Wall St. Rank held LifeMD as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.